Rocket Pharmaceuticals Inc.
RCKT | NASDAQ
$3.27
-$0.10 (-2.97%)
At close: Sep 21, 2026, 4:00 PM ET
$3.27
$0 (0.00%)
Pre-market:
Sep 22, 2026, 4:52 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 11.03M | n/a | n/a | n/a | n/a | 1.15M |
Gross Profit | -11.03M | n/a | n/a | n/a | n/a | -1.15M |
Operating Income | -228.52M | -273.21M | -259.66M | -224.34M | -167.25M | -136M |
Interest Income | 10.62M | 18.22M | 15.94M | 3.89M | 3.07M | 2.15M |
Pretax Income | -223.12M | -258.75M | -245.6M | -221.86M | -169.07M | -139.7M |
Net Income | -223.12M | -258.75M | -245.6M | -221.86M | -169.07M | -146.67M |
Selling & General & Admin | 86.5M | 101.96M | 73.32M | 58.77M | 41.77M | 27.92M |
Research & Development | 142.02M | 171.24M | 186.34M | 165.57M | 125.48M | 106.38M |
Other Expenses | -11.03M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 217.49M | 273.21M | 259.66M | 224.34M | 167.25M | 134.86M |
Interest Expense | 1.89M | 1.89M | 1.88M | 1.91M | 5.89M | 7.55M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 228.52M | 273.21M | 259.66M | 224.34M | 167.25M | 136M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | 6.97M |
Shares Outstanding (Basic) | 111.12M | 94.81M | 84.01M | 68.15M | 63.24M | 55.38M |
Shares Outstanding (Diluted) | 111.12M | 94.81M | 84.01M | 68.15M | 63.24M | 55.38M |
EPS (Basic) | -2.01 | -2.73 | -2.92 | -3.26 | -2.68 | -2.52 |
EPS (Diluted) | -2.01 | -2.73 | -2.92 | -3.26 | -2.68 | -2.52 |
EBITDA | -210.21M | -247.49M | -236.62M | -213.69M | -157.81M | -131.59M |
EBIT | -221.23M | -256.86M | -243.72M | -219.95M | -163.18M | -132.73M |
Depreciation & Amortization | 11.03M | 9.38M | 7.1M | 6.27M | 5.37M | 1.15M |
Add to Watchlist
Select watchlists to add or remove RCKT